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Background: Multidrug resistance is a worrying cause of treatment failure in bacterial infections. The search of
bioactive constituents from medicinal plants against multidrug resistant (MDR) bacteria has significantly evolved in
the two last decades. In the present study, twenty-two compounds (three terpenoids, eleven phenolics and eight
alkaloids) isolated from three Cameroonian medicinal plants, namely Garcinia nobilis, Oricia suaveolens and
Balsamocitrus camerunensis, as well as the crude extracts were tested for their antibacterial activities against
Mycobacterium tuberculosis and Gram-negative bacteria amongst which were MDR active efflux pumps expressing
phenotypes.
Methods: The microplate alamar blue assay (MABA) and the broth microdilution methods were used to determine
the minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of the studied samples.
Results: The results of the MIC determinations indicate that, the best crude extract was that from G. nobilis (GNB),
its inhibitory effects being noted against 12 of the 14 tested bacteria. The extract of GNB also exhibited better
anti-tuberculosis (MIC of 128 μg/mlM. tuberculosis against ATCC 27294 strain) and antibacterial (MIC of 64 μg/ml
against Escherichia coli ATCC10536) activities compared to the extracts of O. suaveolens and B. camerunensis.
Interestingly, 4-prenyl-2-(3,7-dimethyl-2,6-octadienyl)-1,3,5,8-tetrahydroxyxanthone (2), isolated from the most active
extract GNB, also showed the best activity amongst compounds, inhibiting the growth of all the fourteen tested
microorganisms. The lowest MIC value obtained with compound 2 was 8 μg/ml against M. tuberculosis ATCC 27294
and M. tuberculosis clinical MTCS2 strains. Other compounds showed selective activities with 11 of the 14 tested
bacteria being sensitive to the xanthone, morusignin I (5) and the alkaloid, kokusaginine (13).
Conclusions: The results of the present investigation provide evidence that the crude extract from G. nobilis,
O. suaveolens and B. camerunensis as well as some of their compounds, and mostly compound 2 (isolated from
G. nobilis,) could be considered as interesting natural antibacterial products.
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The continuous emergence of multidrug-resistant (MDR)
bacteria drastically reduced the efficacy of our antibiotic
armory and, consequently, increases the frequency of
therapeutic failure. Drug resistance is a consequence of
the worldwide use of antibiotics, and the acute challenge
for health care is to find measures to efficiently combat re-
sistant organisms [1]. Several natural compounds have
successfully been tested for their abilities to prevent the
growth of MDR bacteria [2]. In our continuous search of
antibacterial drugs from natural source, we targeted three
Cameroonian medicinal plants, Garcinia nobilis Engl.
(Clusiaceae), Oricia suaveolens Engl. [Commonly known in
West Africa as Abe iolo or Kru-bete parihi (Ivory Coast) or
Mende jagbole (Sierra Leone)] and Balsamocitrus
camerunensis Letouzey, R. (Rutaceae). Plants of the genus
Garcinia, widely distributed in the tropical Africa, Asia,
New Caledonia, and Polynesia, have yielded many biologic-
ally active and structurally intriguing natural products [3].
Garcinia species are known to contain a wide variety of
oxygenated and prenylated xanthones, as well as poly-
isoprenylated benzophenones such as the guttiferones [4].
Previous studies of the chemistry of the genus Oricia, in-
cluding O. suaveolens revealed the presence of alkaloids
and triterpenes [5,6]. B. camerunensis is a new species
recently found in Batouri (Cameroon) and Boukoko (Cen-
tral African Republic) [7]. Plants of genus Balsamocitrus
(including the decoction of the bark of B. camerunensis)
are used in traditional African medicine to treat malaria,
hypertension, infertility, and influenza [8,9]. Previous phyto-
chemical investigations of this genus revealed the presence
of coumarins, quinoline alkaloids, free aliphatic acids and
steroids, some of these compounds exhibiting potent anti-
bacterial, fungicidal, and algicidal properties [8]. The aque-
ous decoctions of the bark of G. nobilis as well as that of
the roots of O. suaveolens are used in Cameroon to treat
gastro-intestinal infections [Personal communication]. The
combination of the three plants (G. nobilis, O. suaveolens
and B. camerunensis) is also used locally to treat stomach-
ache and diarrheal infections [Personal communication].
The present study was therefore designed to evaluate the
antibacterial activities of the naturally occurring com-
pounds from G. nobilis, O. suaveolens and B. camerunensis




1H and 13C NMR spectra were recorded in chloroform on
Digital NMR BRUCKER AVANCE 400 and 500 MHz.
EIMS were obtained on Joel the MS route JMS.600H and
HREIMS were performed on a thermo finnigan Mat 95
XP. Thin layer chromatography (TLC) and pre-coated
TLC were performed on silica gel GF254 (Merck). Columnchromatography (CC) was performed on silica gel (Merck)
type 100(70–230 Mesh ASTM) eluted either with gradient
system (Hex-Ethyl Acetate-MeOH; Hex-CH2Cl2-MeOH
and Hex-CH2Cl2-Acetone). All the solvents used were dis-
tilled commercial grade. The isolated compounds were
crystallized from the same solvent and their purity was
checked by TLC. Pre-coated plates of silica gel GF254
(Merck) were used for this purpose; the spots were
detected with UV lamp at 254 and 366 nm and by
spraying with 50% H2SO4 or ceric sulfate following by
heating.
Plant material
The stem bark of the G. nobilis was collected in Okola-
Yaounde (Center Region of Cameroon) in April, 2010
whilst O. suaveolens (woods and stem bark), and B.
camerunensis (stem bark) were collected in Nkobi village
(Batouri, East region of Cameroon), in August 2007. The
plants were identified by Mr. Victor Nana of the Cameroon
National Herbarium (Yaoundé) where voucher specimen
(50779/HNC/Cam for G. nobilis, 6161/SRF/Cam for O.
suaveolens and 3785/SRFK for B. camerunensis) were
deposited.
Extraction
The air-dried and powdered samples from each plant
were macerated in either 7.0 L methanol (MeOH) for
the stem bark of G. nobilis (2 kg) or in 10 L MeOH/
dichloromethane (CH2Cl2) mixture for the wood (4 kg)
and roots (3 kg) of O. suaveolens, and the stem bark
(3.8 kg) of B. camerunensis. The extraction was done at
room temperature for two days. The evaporation under
reduced pressure yielded the crude extracts from the
stem bark of G. nobilis (GNB; 100 g), wood (OSW;
173 g) and roots (OSR; 145 g) from O. suaveolens, and
from the stem bark B. camerunensis (BCB; 128 g).
Isolation and identification of compounds from garcinia
nobilis
The compounds from GNB tested herein, caroxanthone
(1), 3-dimethyl-2-geranyl-4-prenylbellidifolin (2), smeath
xanthone A (3), 8-hydroxycudraxanthone G (4) and
morusignin I (5) (Figure 1) were obtained directly from
our chemical bank. We previously reported their isola-
tion and identification from GNB [10].
Isolation and identification of compounds from oricia
suaveolens
One hundred grams of OSW were submitted to vacuum
liquid chromatography (VLC; 25–40 μm, 8 cm × 60 cm,
400 g), eluting with n-hexane-Ethyl acetate (EtOAc ) of in-
creasing polarity. Fractions of 500 mL each were collected
and subsequently pooled on the basis of their thin layer














































































































































Figure 1 Chemical structures of compounds isolated from the stem bark of Garcinia nobilis (1-5), Oricia suaveolens woods (6-11) and
roots (12-17), and the stem back of Balsmocitrus camerunensis (18-22). Caroxanthone (1), 4-prenyl-2-(3,7-dimethyl-2,6-octadienyl)-1,3,5,8-
tetrahydroxyxanthone (2), smeathxanthone A (3), 8-hydroxycudraxanthone G (4), morusignin I (5), stigma-5-en-3-ol (6), lupol (7), evoxanthine 8),
norevoxanthine (9), 1-hydoxy-2,3-dimethoxy-10-methylacridone(10), 1,3-dimethoxy-10-methylacridone (11), skimmianine (12), kokusaginine (13),
montrifoline (14), 1-hydroxy-4-methoxy-10-methylacridone (15), syringaresinol (16), limonin (17), 1-hydroxy-3,6-dimethoxy-8-methylxanthone (18),
xanthoxyletin (19), imperatorin (20), 6,8-dimethoxycoumarin (21), umbelliferone (22).
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fraction 2); 4:6 (1.5 L, 12 g, fraction 3); 2:8 (1.5 L, 15 g,
fraction 4); 0:10 (1 L, 10.5 g, fraction 5)]. Fraction 2 (30 g)
was then subjected to silica gel 60 column chromatog-
raphy (25–40 μm, 6 cm × 60 cm, 100 g), eluting with
n-hexane-EtOAc mixture of increasing polarity. Sub-
fractions (sub-fr) of 100 mL each were collected, then
pooled into nine main sub-frs obtained as follows: n-
hexane- EtOAc 10:0 (1 L, sub-fr A); 9:1 (1.5 L, sub-fr B);
8:2 (1.5 L, sub-fr C); 7.5:2.5 (1 L, sub-fr D); 7:3 (750 mL,
sub-fr E); 6:4 (900 mL, sub-fr F); 5:5 (500 mL, sub-fr G);
3:7 (500 mL, sub-fr H) and pure EtOAC (1 L, sub-fr I).
Stigma-5-en-3-ol C29H50O (6; 88.3 mg; m/z: 414; mp:
250°C) [11] and lupeol C30H50O (7; 57.1 mg; m/z: 426;
mp: 215-216°C) [12] were obtained from sub-frs A (4.2 g)
and B (6.0 g) respectively by recrystallization. Sub-frs A
and B residues were then combined based on their similar
TLC profile to obtain a new sub-fr named AB (7.5 g). The
sub-fr AB was purified on silica gel column (25–40 μm,
4 cm× 60 cm, 80 g) using n-hexane-EtOAc with increas-
ing polarity. Based on their TLC profiles, 15 new sub-frs
of 100 mL each were obtained; evoxanthine C16H13NO4
(8; 30.0 mg; m/z: 283; mp:218-218°C) [13] was obtained
by recrystallisation from new sub-frs 3–6 (n-hexane-
EtOAc 8:2; 7.5:2.5; 7:3; 6.5:3.5) whilst sub-frs 9–12 (n-hex-
ane- EtOAc: 5:5; 4.5:5.5; 4:6; 3:7) yielded evoxanthidine
C15H11NO4 (9; 18.1 mg; m/z: 269; mp:310-312°C) by re-
crystallisation [14].Sub-frs C-D (7 g) were combined on the basis of their
TLC profiles, then subjected to column chromatography
over silica gel (25–40 μm 3 cm× 6 cm, 70 g) and eluted
with the increasing polarity n-hexane- EtOAc to afford
ten other sub-frs. Sub-frs 2–4 (obtained with n-hexane-
EtOAc 7:3; 6:4; 5:5, 2.6 g) yielded 1-hydoxy-2,3-dimethoxy-
10-methylacridone or arborinine C16H15NO4 (10; 12.1 mg;
m/z: 285; mp:175-176°C) [15] and subsequent sub-frs 6–8
(obtained n-hexane- EtOAc 3:7; 2.5:7.5; 2:8) yielded 1,3-
dimethoxy-10-methylacridone C16H13NO3 (11; 8.0 mg;
m/z:269; mp:165°C) [14].
One hundred grams of OSR were partitioned in the
water to obtain sequentially hexane fraction (20.1 g),
CH2Cl2 fraction (24.7 g), acetone fraction (17.0 g) and
the MeOH fraction (32.5 g). The CH2Cl2 crude extract
(24.7 g) was then submitted to VLC on silica gel (25–
40 μm, 8 cm × 60 cm, 100 g) and eluted with hexane-
ethyl acetate gradients: (8:2, 1.5 L), (6:4, 1.5 L), (5:5,
1.25 L), (4:6, 1.25 L), (2:8, 1 L) and finally with pure
EtOAc (500 mL) to give 40 fractions of 250 ml each.
These fractions were pooled on the basis of their TLC
profiles. Fractions 1–17 (10 g), obtained with 80% hex-
ane–EtOAc were subjected to column chromatography
over silica gel (25–40 μm, 4 cm × 60 cm, 65 g) eluting
with hexane-CH2Cl2 with a continuous gradient (95:5 to
7:3) to yield skimmianine C14H13NO4 (12; 2.1 mg; m/z:
259; mp:176-177°C) [16] and kokusaginine C14H13NO4
(13; 7.5 mg; m/z: 259; mp:171°C) [16]. A continuous
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CH2Cl2) yielded four mixtures sub-frs (A-D). Sub-fr B
(2.7 g), showed after examination on TLC precoated plate
a mixture of two compounds. This fraction was further
purified on silica gel column chromatography (25–40 μm;
3 × 15 cm, 15 g) eluting with hexane-CH2Cl2 with a con-
tinuous gradient (6:4 to 3:7) to yield montrifoline
C18H21NO6 (14; 2.7 mg, m/z: 347; mp:1190-192°C) [17]
and 1-hydroxy-3-methoxy-10-methylacridone C15H13NO3
(15; 15.0 mg; m/z: 255; mp:164–165; 174-176°C) [18].
Sub-fr C (2.55 g) was then subjected to silica gel column
chromatography eluting with hexane-CH2Cl2 with a con-
tinuous gradient (6:4 to pure CH2Cl2) to yield (+/−)
syringaresinol C22H26O8 (16; 9.2 mg; m/z: 418; mp:185-
186°C; mp:1175-176°C) [19] whilst combined sub-frs 21–
40 (25 g) obtained from the (1:1) to (1:3) hexane–EtOAc
mixtures and pure EtOAc were subjected successively to
silica gel column chromatography and preparative TLC,
eluting with solvent mixtures (hexane-CH2Cl2-EtOAc) of
increasing polarity to yield limonin C26H30O8 (17;
12.0 mg; m/z: 470; mp:298°C) [20].
Isolation and identification of compounds from
balsamocitrus camerunensis
One hundred and twenty grams of BCB were partitioned
by dissolving in CH2Cl2 to give a soluble (42.0 g) and in-
soluble (76.5 g) fractions. The CH2Cl2 soluble fraction
was subjected to silica gel VLC (25–40 μm, 8 cm ×
60 cm, 120 g) and eluted with the increasing polarity of
n-hexane-EtOAc and MeOH to afford 160 sub-frs of
250 mL each. These sub-frs were pooled on the basis of
TLC analysis into four main fractions (A-D).
Fraction A (12.5 g, combined from sub-frs 1–40) was
column chromatographed over silica gel (25–40 μm, 3.5 -
cm × 50.0 cm) with n-hexane-CH2Cl2 gradient. A total of
40 new sub-fractions of 100 mL each were collected and
pooled on the basis of the TLC analysis. Sub-fr 5–15 were
further column chromatographed over silica gel (25–
40 μm, 2.5 cm × 30.0 cm), using n-hexane-CH2Cl2 (4:1)
mixture as eluent to afford compound 7 (99 mg). Sub-frs
16–40 were further chromatographed over silica gel
column (25–40 μm, 2.5 cm × 30.0 cm), eluting with n-
hexane-CH2Cl2 (1:1) mixture to yield 1-hydroxy-3,6-
dimethoxy-8-methylxanthone or lichexanthone C17H16O4
(18; 5.2 mg; m/z: 284; mp:187-188°C) [21] and xan-
thoxyletin C15H14O4 (19; 7.0 mg; m/z: 258; mp:133°C)
[22]. Fraction B (10.0 g, combined from the sub-frs 41–
79) was purified over silica gel column (25–40 μm, 3.5 ×
50.0 cm) with n-hexane-CH2Cl2 gradient. A total of 50
sub-frs of 100 mL each were collected and pooled on the
basis of TLC analysis. Sub-frs 10 to 40 were further puri-
fied over silica gel column (25–40 μm, 2.5 cm × 30.0 cm)
with a mixture of n-hexane-CH2Cl2 (9 : 1) to yield
imperatorin C16H14O4 (20;12.0 mg, m/z: 270; mp:102°C)[23]. Fraction C (16.5 g, combined from sub-frs 80–110)
was purified over silica gel column (25-40 μm, 3.5 cm ×
50.0 cm) with a Hexane- CH2Cl2 gradient. A total of 45
fractions of 100 mL each were collected and combined on
the basis of their TLC profile. Fractions 10–25 were fur-
ther purified over silica gel column (25–40 μm, 2.5 cm ×
30.0 cm) with CH2Cl2-acetone (4: 1) mixture to afford
scoparone C11H10O4 (21; 8.7 mg; m/z: 206; mp: 144°C)
[24]. Fraction D was further chromatographed on silica gel
column, using CH2Cl2–acetone mixture as eluent, then the
recrystallization in CH2Cl2-acetone (6:4) gave umbelliferone
C9H6O3 (22; 11.0 mg; m/z: 162; mp:230-232°C) [25].
Chemicals for antibacterial assay
Chloramphenicol (Sigma-Aldrich, St. Quentin Fallavier,
France) was used as reference antibiotics (RA) against
Gram-negative bacteria. p-Iodonitrotetrazolium chloride
(INT, Sigma-Aldrich) was used as microbial growth indi-
cator [26,27]. Isoniazid (INH) (Sigma) was used as RA
against M. tuberculosis.
Antibacterial assays
Microbial strains and culture media
The studied microorganisms included reference and clinical
strains (Tables 1 and 2) of Escherichia coli, Enterobacter
aerogenes, Klebsiella pneumoniae, Providencia stuartii,
Pseudomonas aeruginosa, a drug-susceptible strain of M.
tuberculosis H37Rv obtained from the American Type
Culture Collection, and two clinical strains of M. tubercu-
losis MTCS1, MTCS2. M. tuberculosis was plated on
Löwenstein–Jensen medium and allowed to grow for 3–4 -
weeks at 37°C. Middlebrook 7H9 broth supplemented with
0.2% glycerol and 10% Oleic Acid–Albumin–Dextrose–
Catalase (OADC) (Sigma) was used to determine the MIC
and MBC values of the test samples on M. tuberculosis. We
previously reported the features [28] of all the tested Gram-
negative bacteria. Nutrient agar was used for the activation
of bacteria other than M. tuberculosis strains [28]. The
clinical strains used in this work are our laboratory collec-
tion previously obtained from Yaoundé General Hospital
(Cameroon), and from the Mediterranean University
(Marseille, France).
INT colorimetric assay for MIC and MBC determinations
The MIC determinations on Gram-negative bacteria
were conducted using rapid INT colorimetric assay
according to previously described methods [26,27] with
some modifications. The test samples and RA were first
of all dissolved in DMSO/Mueller Hinton Broth (MHB)
or DMSO/7H9 broth. The final concentration of DMSO
was lower than 2.5% and does not affect the microbial
growth [29]. The solution obtained was then added to
MHB, and serially diluted two fold (in a 96- wells
microplate). Then, 100 μl of inoculum 1.5 × 106 CFU/ml




Microorganisms, strains and MIC (μg/ml)b
E. coli E. aerogenes K. pneumoniae P. stuartii P. aeruginosa M. tuberculosis
ATCC 10536 AG 100 AG 102 ATCC 13048 CM 64 EA 27 ATCC 11296 KP55 ATCC 29916 NAE 16 PA 01 PA 124 ATCC 27294 MTCS1 MTCS2
Crude extracts
GNB 64 256 256 256 512 256 128 512 512 - 512 - 128 256 256
OSR 128 512 - 512 - - 256 256 512 256 - - 512 - 512
OSW 128 512 - - - - 128 128 - 128 - - 256 - 512
BCB 512 - - 256 - - 512 512 - - - - - - -
Compounds
1 256 128 - - - - - - - - - - - - -
2 64 64 128 128 256 64 512 512 256 64 64 128 8 32 8
3 128 128 64 256 - 256 - - - - - - 64 - 128
4 - 64 128 - 256 128 - - - - 256 - 512 - 512
5 64 128 128 - - 512 512 - 512 - 64 128 32 64 64
8 512 128 256 - 512 128 512 - - - - - 128 512 256
9 - 128 256 - 256 256 - - - - - - - - -
10 64 128 256 - - 128 - - 512 - - - 128 - 512
11 128 256 128 - 256 512 512 - - - - 512 - - -
13 512 64 256 - 512 128 256 - - - 128 512 256 512 512
15 128 256 256 - - 256 - - - - - - - - -
16 128 128 - - 512 - - 512 - - - 512 - -
17 - 128 - - - - - - - - - - - - -
18 - 256 - - - 256 - - - 256 - - - - -
19 - 256 - - - - - - - - - - - - -
20 - 512 - - - - - - - - - - - - -
21 512 256 - - - 256 256 - - - - - - - -
22 512 256 256 512 128 - - 512 - - - - - - -
RA <4 16 512 64 - 64 4 32 - 64 128 128 1 128 4
aTested samples [methanol-dichloromethane 1:1 extract of the stem bark of Garcinia nobilis (GNB), the wood (OSW)roots (OSR) of Oricia suaveolens, and stem bark of Balsmocitrus camerunensis (BCB); compounds
isolated from the stem bark of Garcinia nobilis (1–5), Oricia suaveolens woods (6–11) and roots (12–17), and the stem back of Balsmocitrus camerunensis (18–22); caroxanthone (1), 4-prenyl-2-(3,7-dimethyl-2,6-
octadienyl)-1,3,5,8-tetrahydroxyxanthone (2), smeathxanthone A (3), 8-hydroxycudraxanthone G (4), morusignin I (5), stigma-5-en-3-ol (6), 20(29)lupen-2-ol (7), evoxanthine (8), norevoxanthine (9), 1-hydoxy-2,3-
dimethoxy-10-methylacridone (10), 1,3-dimethoxy-10-methylacridone (11), kokusaginine (13), 1-hydroxy-4-methoxy-10-methylacridone (15), syringaresinol (16), limonin (17), 1-hydroxy-3,6-dimethoxy-8-methylxanthone




























Microorganisms, strains and MBC (μg/ml)b
E. coli E. aerogenes K. pneumoniae P. stuartii P. aeruginosa M. tuberculosis
ATCC 10536 AG 100 AG 102 ATCC 13048 CM 64 EA 27 ATCC 11296 KP55 ATCC 29916 NAE 16 PA 01 PA 124 ATCC 27294 MTCS1 MTCS2
Crude extracts
GNB 256 512 >512 >512 >512 >512 256 >512 >512 - >512 - 256 >512 512
OSR 256 >512 - >512 - - 512 512 >512 512 - - >512 - >512
OSW 512 >512 - - - - 256 512 - 512 - - 512 - >512
BCB >512 - - 512 - - >512 >512 - - - - - - -
Compounds
1 >512 >512 - - - - - - - - - - - - -
2 128 256 256 256 >512 128 >512 >512 512 128 128 256 16 64 32
3 256 256 128 512 - 512 - - - - - - 128 - 256
4 - 128 256 - 512 256 - - - - 512 - >512 - >512
5 128 256 256 - - >512 >512 - >512 - 128 256 64 128 128
8 >512 256 >512 - >512 256 >512 - - - - - 256 >512 512
9 - 256 >512 - 512 >512 256 - - - - - - - -
10 256 256 512 - - - - - >512 - - - 512 - >512
11 >512 - - - - >512 - - - - - - - - -
13 >512 128 512 - >512 256 512 - - - 256 >512 512 >512 >512
15 256 512 >512 - - 512 - - - - - - - - -
16 256 256 - - >512 - - >512 - - - >512 - -
17 - 256 - - - - - - - - - - - - -
18 - 512 - - - 512 - - - 512 - - - - -
19 - 512 - - - - - - - - - - - - -
20 - >512 - - - - - - - - - - - - -
21 >512 512 - - - 512 512 - - - - - - - -
22 >512 512 512 >512 256 - - >512 - - - - - - -
RA <4 32 >512 128 - 128 8 64 - 128 256 256 2 256 16
aTested samples [methanol-dichloromethane 1:1 extract of the stem bark of Garcinia nobilis (GNB), the wood (OSW)roots (OSR) of Oricia suaveolens, and stem bark of Balsmocitrus camerunensis (BCB); compounds
isolated from the stem bark of Garcinia nobilis (1–5), Oricia suaveolens woods (6–11) and roots (12–17), and the stem back of Balsmocitrus camerunensis (18–22); caroxanthone (1), 4-prenyl-2-(3,7-dimethyl-2,6-
octadienyl)-1,3,5,8-tetrahydroxyxanthone (2), smeathxanthone A (3), 8-hydroxycudraxanthone G (4), morusignin I (5), stigma-5-en-3-ol (6), 20(29)lupen-2-ol (7), evoxanthine (8), norevoxanthine (9), 1-hydoxy-2,3-
dimethoxy-10-methylacridone (10), 1,3-dimethoxy-10-methylacridone (11), kokusaginine (13), 1-hydroxy-4-methoxy-10-methylacridone (15), syringaresinol (16), limonin (17), 1-hydroxy-3,6-dimethoxy-8-methylxanthone
(18), xanthoxyletin (19), imperatorin (20), 6,8-dimethoxycoumarin (21), umbelliferone (22)]; RA: reference antibiotics were chloramphenicol for bacteria, isoniazid for M. tuberculosis; b(−): MBC not determined as the MIC
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plates were covered with a sterile plate sealer, then agi-
tated to mix the contents of the wells using a plate
shaker and incubated at 37°C for 18 h. The assay was re-
peated thrice. Wells containing adequate broth, 100 μl
of inoculum and DMSO to a final concentration of 2.5%
served as negative control. The MIC of samples was
detected after 18 h incubation at 37°C, following
addition (40 μl) of 0.2 mg/ml INT and incubation at
37°C for 30 minutes. Viable bacteria reduced the yellow
dye to a pink. MIC was defined as the sample concentra-
tion that prevented this change and exhibited complete
inhibition of microbial growth. The MBC was deter-
mined by adding 50 μl aliquots of the preparations,
which did not show any growth after incubation during
MIC assays, to 150 μl of adequate broth. These prepara-
tions were incubated at 37°C for 48 h. The MBC was
regarded as the lowest concentration of extract, which
did not produce a color change after addition of INT as
mentioned above [30,31].
Microplate Alamar blue assay (MABA) against
M. Tuberculosis
The activity of all samples against M. tuberculosis strains
was tested using the MABA [32]. Briefly, each of the
above M. tuberculosis strains was cultured at 37°C in
Middlebrook 7H9 broth supplemented with 0.2% gly-
cerol and 10% OADC (oleic acid–albumin–dextrose–
catalase; Sigma) until logarithmic growth was reached.
The homogenous culture was obtained using sterile glass
beads and vortex. About 6×106 CFU/ml inoculum
(100 μl) of M. tuberculosis was then added to the two
fold serially diluted samples (100 μl). The final concen-
tration of DMSO in all assays was 2.5% or less and this
dilution also served as solvent control. The samples were
assayed in triplicate. All tests were carried out in sterile
flat-bottomed 96-well microplates. Each microplate was
incubated for 5 days at 37°C in a sealed plastic CO2-per-
meable bag. After 5 days of incubation, 32 μl of a mix-
ture of freshly prepared Alamar Blue solution and 20%
sterile Tween-80 (Sigma) 1:1 v/v were added to one
growth-control well. The microplates were incubated
again at 37°C for 24 h. If a color shift from blue to pink
was observed in the growth-control sample, 32 μl of
alamar blue solution was added to each of the remaining
wells, and the microplate was further incubated for 24 h.
A well-defined pink color was interpreted as positive
bacterial growth, whereas a blue color indicated an ab-
sence of growth. The MIC corresponded to the greatest
dilution of sample extract in which the color shift from
blue to pink was not observed.
Samples with recorded MIC values following MABA
were assayed for their mycobactericidal effect [32]. Briefly,
5 μl of the undeveloped mycobacterial suspensions weretransferred from the former to a new microplate con-
taining 195 μl of fresh culture medium per well. Three
wells were inoculated with 100 μl of fresh inoculum as for
MABA and three more wells were incubated with 200 μl
of culture medium only, as negative controls. The mi-
croplates were incubated and developed with alamar blue
as for MABA. The MBC corresponded to the minimum
sample concentration that did not cause a color shift in
cultures that were re-incubated in fresh medium.
Results and discussion
The chemical structures of the compounds isolated from
G. nobilis, O. suaveolens and B. camerunensis (Figure 1)
were established by spectroscopic methods. The com-
pounds were isolated from the stem bark of G. nobilis
(1–5), the woods of O. suaveolens (6–11), the roots
(12–17) and the stem bark of B. camerunensis (7, 18–22).
The twenty two isolated compounds were identified as
caroxanthone (1), 4-prenyl-2-(3,7-dimethyl-2,6-octadienyl)-
1,3,5,8-tetrahydroxyxanthone (2), smeathxanthone A (3),
8-hydroxycudraxanthone G (4), morusignin I (5), stigma-5-
en-3-ol (6), lupeol (7), evoxanthine (8), norevoxanthine (9),
1-hydoxy-2,3-dimethoxy-10-methylacridone(10), 1,3-dime
thoxy-10-methylacridone (11), skimmianine (12), koku
saginine (13), montrifoline (14), 1-hydroxy-4-methoxy-
10-methylacridone (15), syringaresinol (16), limonin (17),
1-hydroxy-3,6-dimethoxy-8-methylxanthone (18), xantho
xyletin (19), imperatorin (20), scoparone (21) and umbe
lliferone (22) [11-25]. Amongst the twenty-two com-
pounds were three terpenoids (6, 7 and 17), eleven phen-
olic compounds (1–5, 16, 18–22), and eight alkaloids
(10–17). The isolated terpenoids were steroid (6), triter-
penoid (7), and limonoid (17) whilst the alkaloids included
five acridones (8–11, 15) and three furanoquinolines
(12–14). The phenolics obtained herein were six xan-
thones (1–5, 18), one lignan (16) and four coumarins
(19–22). The isolation and identification of compounds
1–5 from G. nobilis was previously reported [10]. The oc-
currence of alkaloids and terpernoids from O. suaveolens
was reported [5,6], and their isolation in the present study
is in consistence with previous reports. The occurrence of
coumarins, quinoline alkaloids, and free aliphatic acids
was also reported in B. camerunensis [9]. However, in this
study, only coumarins were isolated. The crude extracts as
well as the isolated compounds [excluding compounds 6,
7, 12 (known to have low or no antimicrobial activity),
and 14 (isolated in very low quantities)] were tested for
the antibacterial activities against Gram-negative bacteria
and M. tuberculosis and the results are summarized in
Tables 1 and 2.
The results of the MIC determinations (Table 1) showed
that the crude extract from G. nobilis (GNB) was the most
active amongst the studied extracts, its inhibitory effects
being noted on 12 of the 14 tested bacteria. GNB also
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27294 (MIC of 128 μg/ml) and E. coli ATCC10536 (MIC
of 64 μg/ml) than OSR, OSW and BCB. The inhibitory
effects of the extracts OSR and OSW from O. suaveolens
were noted on 9/14 and 7/14 studied bacteria respectively,
meanwhile that of the extract BCB of B. camerunensis was
observed on 4/14 pathogens tested. Interestingly, com-
pound 2 isolated from the most active extract GNB, also
exhibited the best activity, preventing the growth of all the
fourteen tested microorganisms. The lowest MIC obtained
with compound 2 was 8 μg/ml against M. tuberculosis
ATCC 27294 and the clinical MTCS2 strains. It is note-
worthy that compound 2 was more active than chloram-
phenicol on two Gram-negative MDR bacteria, namely E.
coli AG102 and E. aerogenes CM64 (Table 1). Other com-
pounds showed selective activities, their effects being
noted on 1/14 tested bacteria for compounds 16, 17, 19
and 20; 2/14 for 1; 3/14 for 18; 4/14 for 9 and 21; 5/14 for
22; 7/14 for 3, 4, 10 and 11; 9/14 for 8; and 11/14 for 5
and 13. The results of the MBC determinations (Table 2)
also showed the activities of the studied samples on some
of the tested microorganisms. As observed with MIC data
(Table 1), the lowest MBC value (Table 2) was recorded
with compound 2 (16 μg/ml) against M. tuberculosis
ATCC 27294.
Phytochemicals are routinely classified as antimicro-
bials on the basis of susceptibility tests that produce
MIC in the range of 100 to 1000 μg/ml [33]. The activity
is considered to be significant if MIC values are below
100 μg/ml for crude extract and moderate when the
MICs vary from 100 to 625 μg/ml [34,35]. Also, the ac-
tivity of compounds is considered to be significant when
the MIC is below 10 μg/ml, and moderate when such
values vary between 10 and 100 μg/ml [34,35]. On the
basis of such criteria, the activity of the studied crude
extracts can mostly be considered as moderate, though
a significant effect was observed with GNB on E. coli
ATCC strains. Compound 2 was significantly active
against M. tuberculosis ATCC 27294 and MTCS2 strains.
However its activities can also be considered as moder-
ate against the majority of the bacteria tested. All the
tested compounds were active on at least one of the
studied microorganisms, and their presence can explain
the activity of the crude extracts. Nonetheless, it can be
observed that the activity of GNB was not detected on
both P. stuartii ATCC NAE16 and P. aeruginosa PA124,
while the extract yielded at least one active compound
on these bacteria (Table 1). This can be explained by the
fact that the activity of the crude extract does not only
depend on the presence of the active compounds, but is
also influenced by the quantity and/or possible inter-
action with other constituents of the plant. This obser-
vation can also be applied when carefully analysing the
activities of the crude extracts from O. suaveolens and B.camerunensis and their constituents (Table 1). The activ-
ity of the crude extracts and compounds studied herein
(and mostly compound 2) can be considered interesting
when regarding the medical importance of the studied
bacteria. In fact, the clinical MDR Gram-negative bac-
teria tested express active efflux pumps and are involved
in many therapeutic failures [28]. To the best of our
knowledge, the antibacterial activities of the extracts of
G. nobilis, O. suaveolens and B. camerunensis as well as
those of most of the studied compounds are being
reported for the first time. Nevertheless, some of the iso-
lated compounds were reported for their antibacterial
properties. In effect, lupeol (7) is known to have low
antibacterial activities, the lowest MIC value obtained
against Enterococcus faecalis ATCC 29212 being 63 μg/
ml [36]. The activity of compound 7 was also not
detected against the sensitive Mycobacterium smegmatis
when it was tested at a concentration up to 312 μg/ml
[37] and consequently, this compound was not tested
again in this work. Previously we also reported the mod-
erate activity of the alkaloid 13 on some sensitive Gram-
negative bacteria as well as it low effect against M.
smegmatis [37]. This compound was not more active
against MDR bacteria as observed in the present work,
confirming its low antibacterial potential. It has also been
demonstrated that compounds 3 (active only on two of 21
tested microorganisms) [38] and 16 (inhibition zone diam-
eters for 10 μl discs at 104 ppm reported as 0.0; 0.2; 0.4
and 0.5 mm against K. pneumoniae, S. aureus, Pseudo-
monas syringae and Bacillus subtilis respectively) [39]
have low antibacterial activities. Such reports are in ac-
cordance with the results obtained in the present study.
Though compounds 17 (limonin) and 20 (imperatonin)
showed poor activities as reported herein, their antilisterial
inhibitory effects were found moderate, the MIC values
obtained against five Listeria monocytogenes ATCC strains
varying between 15.62-31.25 μg/ml [40].
Compounds 19 (xanthoxyletin) and 22 (umbelliferone)
were also found inactive against M. tuberculosis and
poorly active against Gram-negative bacteria, consolidat-
ing the previously reported data [41,42]. It is noteworthy
that compound 12 was reported not to have any bacter-
ial activity [43] and was not tested in the present work.
When regarding the structure-activity relationship, it
appears that coumarins had the lowest activities, none of
them been active against M. tuberculosis. The tested
tetranortriterpenoid, compound 17 also showed very
weak antibacterial activities. These results are in consist-
ence with previous studies, showing the low antibacterial
activities of terpenoids and coumarins against bacteria
expressing MDR phenotype [2]. Alkaloids also showed
low antibacterial activities. However moderate inhibitory
effects were noted with 10 (1-hydoxy-2,3-dimethoxy-10-
methylacridone) and 13 (kokusaginine) respectively
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Amongst alkaloids, compound 13, one of the three iso-
lated furanoquinolines, showed the best spectrum of
activity (contrary to the five acridone alkaloids) and was
found active on both M. tuberculosis and Gram-negative
bacteria. Within the acridone alkaloids, and when com-
paring the effects of compounds 10 and 15 [antibacterial
spectra (7/14 of the tested bacteria for 10 and 4/14 for
15); lowest MIC value (64 μg/ml for 10 and 128 μg/ml
for 15)], it appears that the presence of methoxyl-
(−OCH3) group in C2 (compound 10) increases the bac-
terial susceptibility (Figure 1, Table 1). A comparison of
the activities of compounds 8 and 9 [the presence of –
OCH3 group in C1 (compound 8) instead of –OH group
(compound 9)] on one hand, and those of 11 and 15
[the presence of –OCH3 group in C1 (compound 11) in-
stead of the hydroxyl (−OH) group (compound 15)] on
another hand seems to confirm the fact that the natural
substitution of –OCH3 by –OH in the studied alkaloids
increases their activities (Figure 1, Table 1). The best
antibacterial activities were recorded with xanthones.
Within the studied xanthones and when regarding the
activities of compounds 2 and 3, it appears that the pres-
ence of additional prenyl- group in C4 significantly in-
creases the antibacterial activity (Figure 1, Table 1).
Between compounds 4 and 5, it can also be deduced that
the cyclisation increase the activity (Figure 1, Table 1).
Conclusion
The results of the present investigation are important, in
regards to the medical importance of the studied mi-
croorganisms. Hence, these data provide evidence that
some of the constituents of G. nobilis, O. suaveolens and
B. camerunensis and mostly compound 2 (isolated from
G. nobilis), as well as some of the crude extracts from
the three plants could be potential antimicrobial pro-
ducts to fight MDR bacteria. The combination of the
three plants as used locally in the treatment of infections
will further be investigated to provide better understand-
ing to the traditional use.
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